UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 20, 2020
Accession Number:
0001104659-20-035405
Submission Type:
POS AM
CIK:
0001606645
Company Name:
Foamix Pharmaceuticals Ltd.
File Number:
333-224084